Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Biotech’s Regeneron Is a New Game Changer Buy

By Hilary Kramer, Editor, GameChangers
Biotech's Regeneron is a strong buy based on its existing Eylea drug for macular degeneration, but the company also has a solid pipeline of products.

New Auto Ad Strategies Energize the Sector

By Lawrence Meyers, InvestorPlace Contributor
Big increases in the automakers' ad spending to help local dealerships should propel further sales gains -- and create opportunity for investors.

3 Blue Chip Stocks to Fight the Market Blues

By Louis Navellier, Editor, Growth Investor
Three strong blue chip companies can form the basis of a solid portfolio, and these three are running in high gear and should be added to your portfolio.

At Toro, It’s Not Just the Grass That’s Green

By Lawrence Meyers, InvestorPlace Contributor
The grounds-keeping equipment maker's earnings are on a tear -- and it's growing at a 15% clip.

CAT Is Set for a Strong Second Half

By Dan Burrows, InvestorPlace Feature Writer
China's stimulus package should be just the catalyst Caterpillar's stock needs to enjoy a strong remainder of the year.

Down but Not Out: JPM Will Rebound

By Hilary Kramer, Editor, GameChangers
JPM’s stock is massively oversold, but it is no reflection on the health of the business. The company itself is strong and healthy -- in fact, it’s thriving.

Top 6 Stocks to Buy for June

By Sam Collins, InvestorPlace Chief Technical Analyst
This month’s top stocks to buy are all large-cap, high-quality dividend producers with a history of holding their uptrends in similar market conditions.

My Favorite Sector for Summer: Biotech

By James Brumley, InvestorPlace Feature Writer
Stocks can suck in the summertime, but not every sector is doomed: Here's why biotech could be the season's sweetheart, and which stocks look hot.

7 Biotech Stocks to Add to Your Portfolio

By Portfolio Grader
The biotech business is working overtime to find the next breakthrough drugs and treatments for a population that gets older every day.

4 Stocks Buffett May Be Buying in Europe

By Bryan Perry
A look at the Oracle's buying behavior in the past clues you in to where his cash is likely being funneled now.

10 Companies Increasing Dividends

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader
This week’s batch of dividend divas includes a fashion icon, an agribusiness giant, a specialty chemical maker and one of the most famous food brands.

3 Hospital Stocks for a Healthy Portfolio

By Susan J. Aluise, Aviation, Auto & Transportation Writer
No matter if Obamacare thrives or gets thrashed, these name should prosper because they're making moves now that will pay off down the road either way.

Are Big Banks — or Any Banks — a Buy?

By Will Ashworth, InvestorPlace Contributor
With JPMorgan Chase and many of the big banks still making a mess of things, one has to wonder about their future -- and their worth as investments.

Banking Customers Have Found Smaller, Greener Pastures

By James Brumley, InvestorPlace Feature Writer
Big banks' customers actually are following through on threats to move their money elsewhere -- and much of that money is headed into regionals and S&L firms.

10 Tech Giants to Add Portfolio Value

By Portfolio Grader
The technology sector still has some red-hot values for companies that lead the way in products and technology. Here are 10 picks to buy in this sector.

BDCs = Mega-Dividends!

By Lawrence Meyers, InvestorPlace Contributor
Business-development companies offer generous fixed income and access to private-equity investments.

Lehman’s Legacy Shadows Facebook’s Market Effect

By Richard Band
The Facebook IPO legacy may be that of Lehman's 2008 collapse, as investors piled out of stocks in fear. Don't be scared, by aware of strong buys and strategies

American Eagle Just Keeps on Flying High

By Louis Navellier, Editor, Growth Investor
Retailer American Eagle Outfitters continues to show great sales and revenue growth, and with buying pressure high, AEO is a strong portfolio opportunity.

Hold Your Horses on the Penney Pounding

By Lawrence Meyers, InvestorPlace Contributor
Bill Ackman, whose hedge fund owns about 26% of JCP and brought in CEO Ron Johnson, thinks JCP remains a great opportunity. Here's why.
Load More Articles